SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3oaz'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SU9_A_ACTA426_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		3 / 3 GLN H   3
GLU H   1
LYS H   1
 None
 0.96A 3su9A-3oazH:
undetectable		 3su9A-3oazH:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.89A 4qvnH-3oazH:
undetectable
4qvnI-3oazH:
undetectable		 4qvnH-3oazH:
20.32
4qvnI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 10 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.89A 4qvnV-3oazH:
undetectable
4qvnW-3oazH:
undetectable		 4qvnV-3oazH:
20.32
4qvnW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.87A 4qvpH-3oazH:
undetectable
4qvpI-3oazH:
undetectable		 4qvpH-3oazH:
20.32
4qvpI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.87A 4qvpV-3oazH:
undetectable
4qvpW-3oazH:
undetectable		 4qvpV-3oazH:
20.32
4qvpW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.88A 4qvqH-3oazH:
undetectable
4qvqI-3oazH:
undetectable		 4qvqH-3oazH:
20.32
4qvqI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.87A 4qvqV-3oazH:
undetectable
4qvqW-3oazH:
undetectable		 4qvqV-3oazH:
20.32
4qvqW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.93A 4qvvH-3oazH:
undetectable		 4qvvH-3oazH:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.93A 4qvvV-3oazH:
undetectable		 4qvvV-3oazH:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.94A 4qvyH-3oazH:
undetectable		 4qvyH-3oazH:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.94A 4qvyV-3oazH:
undetectable
4qvyW-3oazH:
undetectable		 4qvyV-3oazH:
20.32
4qvyW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qw0H-3oazH:
undetectable
4qw0I-3oazH:
undetectable		 4qw0H-3oazH:
20.32
4qw0I-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qw0V-3oazH:
undetectable
4qw0W-3oazH:
undetectable		 4qw0V-3oazH:
20.32
4qw0W-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qw1H-3oazH:
undetectable
4qw1I-3oazH:
undetectable		 4qw1H-3oazH:
20.32
4qw1I-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qw1V-3oazH:
undetectable
4qw1W-3oazH:
undetectable		 4qw1V-3oazH:
20.32
4qw1W-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qwuH-3oazH:
undetectable
4qwuI-3oazH:
undetectable		 4qwuH-3oazH:
20.32
4qwuI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 4qwuV-3oazH:
undetectable
4qwuW-3oazH:
undetectable		 4qwuV-3oazH:
20.32
4qwuW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.91A 5bxnH-3oazH:
undetectable
5bxnI-3oazH:
undetectable		 5bxnH-3oazH:
19.43
5bxnI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.90A 5cz7V-3oazH:
undetectable
5cz7W-3oazH:
undetectable		 5cz7V-3oazH:
20.32
5cz7W-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.91A 5d0xV-3oazH:
undetectable		 5d0xV-3oazH:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.87A 5l5fH-3oazH:
undetectable
5l5fI-3oazH:
undetectable		 5l5fH-3oazH:
20.32
5l5fI-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.88A 5l5fV-3oazH:
undetectable
5l5fW-3oazH:
undetectable		 5l5fV-3oazH:
20.32
5l5fW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.92A 5l66H-3oazH:
undetectable
5l66I-3oazH:
undetectable		 5l66H-3oazH:
20.32
5l66I-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
 None
 0.93A 5l66V-3oazH:
undetectable
5l66W-3oazH:
undetectable		 5l66V-3oazH:
20.32
5l66W-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A94_B_ZOTB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 3oaz FAB 2G12, HEAVY
CHAIN
(Homo
sapiens) 		6 / 12 VAL H 193
THR H 137
LEU H 166
VAL H 171
GLY H 169
VAL H 225
 None
 1.50A 6a94B-3oazH:
undetectable		 6a94B-3oazH:
18.32